46 related articles for article (PubMed ID: 10743152)
1. [Clinical significance of beta 2-microglobulin content in nasopharyngeal secretion].
Cui D; Su M; Jie Y
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Jun; 32(3):148-50. PubMed ID: 10743152
[TBL] [Abstract][Full Text] [Related]
2. [Serum beta 2-microglobulin determination in nasopharyngeal carcinoma patients. An analysis of 139 cases].
Luo ZM
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(4):239-40, 256. PubMed ID: 1298313
[TBL] [Abstract][Full Text] [Related]
3. [Significance of serum vascular endothelial growth factor test before radiotherapy in patients with nasopharyngeal carcinoma].
Zhao GQ; Xu Y; Wang Q
Zhong Xi Yi Jie He Xue Bao; 2005 Jul; 3(4):274-7. PubMed ID: 16009104
[TBL] [Abstract][Full Text] [Related]
4. [Clinical observation of TNF-alpha content in nasopharyngeal secretion of patients with nasopharyngeal carcinoma].
Cui D; Zhao Y; Deng Y; Luo G; Su M; Chen X
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 May; 15(5):202-3. PubMed ID: 12541761
[TBL] [Abstract][Full Text] [Related]
5. [Detection of bate 2-microglobulin fibronection and interleukin 2 content in patients with nasopharyngeal carcinoma].
Lin Q; Fu F; Zhang G
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Nov; 15(11):499-500. PubMed ID: 12541829
[TBL] [Abstract][Full Text] [Related]
6. Tissue polypeptide antigen (TPA) and beta 2-microglobulin (beta 2-MG) as tumour markers in nasopharyngeal cancer.
Sundram FX; Aw SE
Ann Acad Med Singap; 1986 Oct; 15(4):507-10. PubMed ID: 3551779
[TBL] [Abstract][Full Text] [Related]
7. Beta-2-microglobulin (beta 2M) as a tumor marker in nasopharyngeal carcinoma.
Lee JK; Tsai SC; Hsieh JF; Ho YJ; Sun SS; Kao CH
Anticancer Res; 2000; 20(6C):4765-8. PubMed ID: 11205215
[TBL] [Abstract][Full Text] [Related]
8. Sp1 is over-expressed in nasopharyngeal cancer and is a poor prognostic indicator for patients receiving radiotherapy.
Wang J; Kang M; Qin YT; Wei ZX; Xiao JJ; Wang RS
Int J Clin Exp Pathol; 2015; 8(6):6936-43. PubMed ID: 26261581
[TBL] [Abstract][Full Text] [Related]
9. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Livin expression in nasopharyngeal carcinoma after radiotherapy.
Liu AH; He AB; Tong WX; Peng XL; Tian Q; Wang H; Li XG; Xu HL
Cancer Radiother; 2016 Jul; 20(5):384-90. PubMed ID: 27373721
[TBL] [Abstract][Full Text] [Related]
11. [Detection of KIAA1173 gene expression in nasopharyngeal carcinoma tissues and cell lines on tissue microarray].
Zhang SQ; Peng H; Song LY; Li XM; Jiang HY; Yao KT; Zhao T
Ai Zheng; 2005 Nov; 24(11):1322-6. PubMed ID: 16552956
[TBL] [Abstract][Full Text] [Related]
12. [Expression of connexin43 and connexin45 in nasopharyngeal carcinoma].
Xiang Q; Fan SQ; Li J; Tan C; Xiang JJ; Zhang QH; Wang R; Li GY
Ai Zheng; 2002 Jun; 21(6):593-6. PubMed ID: 12452056
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profile changes and possible molecular subtypes in differentiated-type nonkeratinizing nasopharyngeal carcinoma.
Wang S; Li X; Li ZG; Lu J; Fang WY; Ding YQ; Yao KT
Int J Cancer; 2011 Feb; 128(4):753-62. PubMed ID: 20473882
[TBL] [Abstract][Full Text] [Related]
14. Loss of cytoplasmic KLF4 expression is correlated with the progression and poor prognosis of nasopharyngeal carcinoma.
Liu Z; Yang H; Luo W; Jiang Q; Mai C; Chen Y; Zhen Y; Yu X; Long X; Fang W
Histopathology; 2013 Sep; 63(3):362-70. PubMed ID: 23758499
[TBL] [Abstract][Full Text] [Related]
15. Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.
Ma BB; Leungm SF; Hui EP; Mo F; Kwan WH; Zee B; Yuen J; Chan AT
Cancer; 2004 Aug; 101(4):776-81. PubMed ID: 15305409
[TBL] [Abstract][Full Text] [Related]
16. [Association of CXCR4 and SDF-1alpha with organ-specific metastasis of nasopharyngeal carcinoma].
Luo HN; Li XP; Liu X; Zhang GH; Liu YL
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):260-4. PubMed ID: 19615279
[TBL] [Abstract][Full Text] [Related]
17. Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis.
Cheng AL; Huang WG; Chen ZC; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Peng F; Duan CJ; Xiao ZQ
J Proteome Res; 2008 Jun; 7(6):2415-26. PubMed ID: 18433155
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue].
Jiang WH; Zhao SP; Yin ZH; Li F; Chen ZH; Xiao JY
Ai Zheng; 2005 Jul; 24(7):796-800. PubMed ID: 16004803
[TBL] [Abstract][Full Text] [Related]
19. [Expression and Significance of Notch1, P21WAF1 and involucrin in nasopharyngeal carcinoma].
Wang M; Li JT; Zeng YX; Hou JH; Lin QQ
Ai Zheng; 2005 Oct; 24(10):1230-4. PubMed ID: 16219138
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma.
Zhou L; Feng X; Shan W; Zhou W; Liu W; Wang L; Zhu B; Yi H; Yao K; Ren C
Oncology; 2007; 72(5-6):357-63. PubMed ID: 18187958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
